As new and emerging immunotherapies, antibody-drug conjugates, targeted therapies, and combination approaches are revolutionizing individualized treatment for metastatic urothelial carcinoma (mUC) patients, it is critical to stay current on the latest approvals, clinical efficacy and safety, biomarker indications, and patient-centric care strategies. In this interactive Clinical Case Challenge: apply your clinical reasoning skills to a real-world patient scenario test your skills in differentiating available treatment options and applying patient-, disease-, and treatment-specific factors to patient-centric treatment and management plans compete with other healthcare professionals for the top spot on the leaderboard receive real-time feedback via expert-led, microlearning videos with key supporting evidence. This activity is delivered in partnership with Cancer Care.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/effectively-individualizing-bladder-cancer-treatment-selection-incorporating
- Start Date: 2024-08-23 05:00:00
- End Date: 2024-08-23 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Gilead Sciences, Inc. - Amount: 36250.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology